Johnson & Johnson One Johnson & Johnson Plaza New Brunswick,
NJ 08933 United States - Map Phone: 732-524-0400 Fax: 732-214-0332 Website: http://www.jnj.com
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers products used in the baby care, skin care, oral care, wound care, and womens health fields, as well as nutritional and over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSONS, AVEENO, CLEAN & CLEAR, NEUTROGENA, RoC, LUBRIDERM, DABAO, VENDÔME, LISTERINE, REMBRANDT, REACH, BAND-AID, NEOSPORIN, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products directly, as well as through surgical supply and other distributors to wholesalers, hospitals, and retailers. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Key Statistics
| |
| Johnson & Johnson’s ISS Governance QuickScore as of May 1, 2013 is 1. The pillar scores are Audit: 10; Board: 2; Shareholder Rights: 4; Compensation: 1. | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Alex Gorsky ,
53 Chairman, Chief Exec. Officer, Chairman of Exec. Committee and Chairman of Fin. Committee | 4.65M | 0.00 | Mr. Dominic J. Caruso ,
55 Chief Financial Officer, VP of Fin. and Member of Exec. Committee | 3.89M | 414.00K | Dr. Paul A. Stoffels Ph.D.,
51 Chief Scientific Officer, Worldwide Chairman of Pharmaceuticals and Member of Exec. Committee | 3.29M | 7.00K | Mr. Peter M. Fasolo Ph.D.,
50 VP of Global HR and Member of Exec. Committee | 1.28M | 0.00 | Ms. Sandra E. Peterson ,
54 Group Worldwide Chairman and Member of Exec. Committee | 398.00K | 0.00 |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|